FDA Announces Plans to Restrict Non-Approved GLP-1 Drugs in Compounded Medications
By
randycupertino
Pale, doughy, and a touch sad. Eat if peckish.
Summary
The FDA is announcing its intent to take action against non-FDA-approved GLP-1 drugs, specifically targeting GLP-1 active pharmaceutical ingredients used in compounded drugs that are being mass-marketed by companies. The agency plans to restrict these ingredients in compounded medications that haven't received FDA approval.
Key quotes
· 3 pulledToday, the U.S. Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies
the U.S. Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients
APIs intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies
You might also wanna read
Nieuwe regels in juni: neutrale verpakkingen voor meer tabaksproducten, HPV-vaccin goedkoper, ecocheques voor fairtrade
Vanaf 1 juni 2025 worden de regels voor neutrale verpakkingen van tabaksproducten uitgebreid naar sigaren, cigarillo's, pijptabak, rookappar
vrtnws.be·1d ago
WHO chief urges community cooperation to contain Ebola outbreak in eastern DRC
The World Health Organization's director general, Tedros Adhanom Ghebreyesus, appealed for community cooperation in containing the Ebola out
theguardian.com·5h ago
Cambridge hospital meets NHS waiting list target ahead of 2026 deadline
New NHS data shows waiting lists at Cambridge hospital are improving, with the national target of having at least 65% of patients waiting no
cambridge-news.co.uk·7h ago
Brazil monitors two patients for possible Ebola as DR Congo outbreak surpasses 1,000 cases
Brazil is monitoring two patients for possible Ebola infection amid the ongoing outbreak in DR Congo, which has over 1,000 suspected cases a
bbc.co.uk·16h ago
Duke Health settles $3.7M class-action lawsuit over patient data shared with Meta
Duke University Health System has reached a $3.7 million class-action settlement after patients alleged their personal data was shared with
share.google·21h ago
FTC Finalizes $7.8 Million Penalty Against BetterHelp for Sharing Patient Health Data with Advertisers
The Federal Trade Commission (FTC) has finalized an order against online counseling service BetterHelp, requiring it to pay $7.8 million and
ftc.gov·21h ago